rs759411189
Variant summary
Our verdict is Pathogenic. The variant received 18 ACMG points: 18P and 0B. PVS1PM2PP5_Very_Strong
The NM_016180.5(SLC45A2):c.1273delC(p.Leu425TrpfsTer9) variant causes a frameshift change. The variant allele was found at a frequency of 0.00000496 in 1,614,120 control chromosomes in the GnomAD database, with no homozygous occurrence. Variant has been reported in ClinVar as Pathogenic (★★). Synonymous variant affecting the same amino acid position (i.e. L425L) has been classified as Likely benign. Variant results in nonsense mediated mRNA decay.
Frequency
Consequence
NM_016180.5 frameshift
Scores
Clinical Significance
Conservation
Publications
- oculocutaneous albinism type 4Inheritance: AR Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Labcorp Genetics (formerly Invitae), Orphanet, Ambry Genetics, G2P
Genome browser will be placed here
ACMG classification
Our verdict: Pathogenic. The variant received 18 ACMG points.
Variant Effect in Transcripts
ACMG analysis was done for transcript: NM_016180.5. You can select a different transcript below to see updated ACMG assignments.
RefSeq Transcripts
| Selected | Gene | Transcript | Tags | HGVSc | HGVSp | Effect | Exon Rank | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|---|
| SLC45A2 | NM_016180.5 | MANE Select | c.1273delC | p.Leu425TrpfsTer9 | frameshift | Exon 6 of 7 | NP_057264.4 | ||
| SLC45A2 | NM_001012509.4 | c.1273delC | p.Leu425TrpfsTer9 | frameshift | Exon 6 of 6 | NP_001012527.2 |
Ensembl Transcripts
| Selected | Gene | Transcript | Tags | HGVSc | HGVSp | Effect | Exon Rank | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|---|
| SLC45A2 | ENST00000296589.9 | TSL:1 MANE Select | c.1273delC | p.Leu425TrpfsTer9 | frameshift | Exon 6 of 7 | ENSP00000296589.4 | ||
| SLC45A2 | ENST00000382102.7 | TSL:1 | c.1273delC | p.Leu425TrpfsTer9 | frameshift | Exon 6 of 6 | ENSP00000371534.3 | ||
| SLC45A2 | ENST00000510600.1 | TSL:3 | c.*10delC | downstream_gene | N/A | ENSP00000424010.1 |
Frequencies
GnomAD3 genomes AF: 0.00000657 AC: 1AN: 152226Hom.: 0 Cov.: 33 show subpopulations
GnomAD2 exomes AF: 0.0000159 AC: 4AN: 251490 AF XY: 0.00 show subpopulations
GnomAD4 exome AF: 0.00000479 AC: 7AN: 1461894Hom.: 0 Cov.: 33 AF XY: 0.00000275 AC XY: 2AN XY: 727248 show subpopulations
Age Distribution
GnomAD4 genome AF: 0.00000657 AC: 1AN: 152226Hom.: 0 Cov.: 33 AF XY: 0.00 AC XY: 0AN XY: 74368 show subpopulations
Age Distribution
ClinVar
Submissions by phenotype
not provided Pathogenic:2
This sequence change creates a premature translational stop signal (p.Leu425Trpfs*9) in the SLC45A2 gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in SLC45A2 are known to be pathogenic (PMID: 21458243, 26573111). This variant is present in population databases (rs759411189, gnomAD 0.007%). This premature translational stop signal has been observed in individual(s) with clinical features of SLC45A2 related conditions (PMID: 26818737, 31077556). ClinVar contains an entry for this variant (Variation ID: 209971). Algorithms developed to predict the effect of sequence changes on RNA splicing suggest that this variant may disrupt the consensus splice site. For these reasons, this variant has been classified as Pathogenic.
Observed in homozygous state or in the presence of a second SLC45A2 variant in multiple unrelated patients with oculocutaneous albinism in the literature and not observed in homozygous state in controls (PMID: 26818737, 31077556, 28976636); Frameshift variant predicted to result in protein truncation or nonsense mediated decay in a gene for which loss of function is a known mechanism of disease; This variant is associated with the following publications: (PMID: 38337174, 36553465, 26818737, 31077556, 28976636)
Oculocutaneous albinism type 4 Pathogenic:1
Oculocutaneous albinism type 4;C2673584:SKIN/HAIR/EYE PIGMENTATION 5, BLACK/NONBLACK HAIR Pathogenic:1
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at